Home › Rheumatoid Arthritis › California › Los Angeles
Rheumatoid Arthritis clinical trials in Los Angeles, CA
3 studies for Rheumatoid Arthritis are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RA-PRO PRAGMATIC TRIAL
RecruitingPhase 3
- Pacific Arthritis Care Center, Los Angeles
- University of California, Los Angeles, Los Angeles
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
RecruitingPhase 2
- Cedars Sinai Medical Center, Los Angeles
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Los Angeles, Los Angeles
About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, and stiffness in your joints. Your risk increases as you become an older adult.
More about Rheumatoid Arthritis on MedlinePlus
Rheumatoid Arthritis trials in other cities
- Houston, TX11 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Dallas, TX7 studies
- Aurora, CO7 studies
- Altoona, PA7 studies
- Boston, MA7 studies
- Plantation, FL6 studies
- San Diego, CA6 studies
- Chicago, IL6 studies
- West Palm Beach, FL5 studies
- Miami, FL5 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.